Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-100 plus radiation in locally advanced cervical cancer
NCT02247232Phase 3Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Dec 2014
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of Z-100 in Cervical Cancer (CC), sponsored by Zeria Pharmaceutical Co., Ltd.. Started Dec 2014; status: completed.
02
Drugs
Z-100
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02247232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247232.